Our study revealed that the HMGB1/ZNF460/BECN1 axis contributes to radioresistance and autophagy in CRC, suggesting that HMGB1 could be a potential therapeutic target for enhancing the response of CRC to radiation therapy. Here, ZNF460 is linked to colorectal carcinoma.